Faculty profile

Nader Sadeghi

ResearcherOtolaryngologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Nader Sadeghi

Researcher

Otolaryngology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
51 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

116

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Neoadjuvant Chemotherapy Oropharyngeal Cancer

Latest papers

Clinicopathological, Molecular, and Economic Outcomes of Bethesda III and IV Thyroid Nodules Following Implementation of a Publicly Funded ThyroSeq v3 Program: A Retrospective Two-Center Cohort Study.
Cancers · 2026
Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
JAMA dermatology · 2026
Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life.
Head & neck · 2026

All 63 publications

Latest funding

Identification of biological properties and molecular signatures to predict treatment response in patients with advanced HPV positive oropharyngeal cancer
CIHR · 2021 · Principal investigator
$665,550
Role of CD109 in regulating cellular signaling and responses in skin and oral squamous cell carcinoma cells
CIHR · 2018 · Co-investigator
$1,074,825
Implementing an e-Intervention to Reduce Anxiety Symptoms and Improve Psychosocial Oncology Uptake In Patients Newly Diagnosed With Head and Neck Cancer: Pilot Randomized Controlled Trial
CIHR · 2017 · Co-investigator
$275,400

All 3 grants and awards

63 publications.

Clinicopathological, Molecular, and Economic Outcomes of Bethesda III and IV Thyroid Nodules Following Implementation of a Publicly Funded ThyroSeq v3 Program: A Retrospective Two-Center Cohort Study.

Savoia G, Payne SB, Vaitzner M, Bandargal S, Hier MP, Mascarella MA, Richardson K, Mlynarek A, Sadeghi N, Wurzba SDS, Azzam R, Mitmaker EJ, Gilfix BM, Pusztaszeri M, Forest VI, Payne RJ

Cancers2026

DOI: 10.3390/cancers18162695 PMID: 42650006

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Haidar S, Mlynarek A, Lefrancois P, Roshdy O, Khanna M, Fortier-Riberdy G, Richardson K, Florianova L, Pusztaszeri M, Caglar D, Sadeghi N, Hier M, Sultanem K, Tsien C, Bouganim N, Esfahani K, Mascarella MA

JAMA dermatology2026

DOI: 10.1001/jamadermatol.2026.1331 PMID: 42201687

Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life.

Deamond H, Devault-Tousignant C, Lang J, Lo C, Silver J, Sadeghi N, Rosberger Z, Frenkiel S, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Chartier G, Mascarella M, Sultanem K, Shenouda G, Cury F, Henry M

Head & neck2026

DOI: 10.1002/hed.70231 PMID: 41810532

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Mascarella MA, Mlynarek A, Richardson K, Vendra V, Solari M, Duvvuri U, Kim S, Sridharan S, Kubik M, Ferris R, Sultanem K, Tsien C, Shenouda G, Bouganim N, Esfahani K, Sadeghi N, Hier M, Kergoat MJ

Oral oncology2026

DOI: 10.1016/j.oraloncology.2026.107943 PMID: 41905240

Prognostic Impact of Lymphovascular Invasion on Distant Metastasis in HPV-Negative Head and Neck Cancer.

Khoury M, Mlynarek A, Richardson K, Sadeghi N, Hier M, Tsien C, Shenouda G, Sultanem K, Bouganim N, Esfahani K, Wurzba S, Mascarella M

Head & neck2026

DOI: 10.1002/hed.70469 PMID: 42712188

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Chowdhury R, Mlynarek AM, Richardson K, Sadeghi N, Hier MP, Wurzba S, Esfahani K, Bouganim N, Sultanem K, Shenouda G, Tsien C, Mascarella MA

Head & neck2026

DOI: 10.1002/hed.70101 PMID: 41257342

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full Trial.

Henry M, Cohen SR, Heyland DK, Platt R, Zhang X, Gotlieb W, Lau S, Vasilevsky CA, Hier M, Sadeghi N, Sultanem K, Batist G, Costa M, Bolster-Foucault C, Wang CS, Agulnik J

Psycho-oncology2026

DOI: 10.1002/pon.70421 PMID: 41856946

Single-stage functional lateral hemilaryngocricoidectomy for a locally advanced chondrosarcoma invading the hemicricoid.

Silver JA, Arif R, Zeitouni A, Sadeghi N

BMJ case reports2026Senior author

DOI: 10.1136/bcr-2024-261525 PMID: 41500712

Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.

McNicoll MM, Mlynarek AM, Richardson K, Hier M, Sadeghi N, Casola A, Bouganim N, Esfahani K, Tsien C, Shenouda G, Sultanem K, Mascarella MA

Head & neck2026

DOI: 10.1002/hed.70015 PMID: 40799173

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Chowdhury R, Botros K, Richardson K, Mlynarek AM, Sadeghi N, Hier MP, Wurzba S, Esfahani K, Bouganim N, Sultanem K, Shenouda G, Tsien C, Mascarella MA

Head & neck2025

DOI: 10.1002/hed.28212 PMID: 40491270

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Neoadjuvant Chemotherapy Dear Professor Sadeghi, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Clinicopathological, Molecular, and Economic Outcomes of Bethesda III and IV Thyroid Nodules Following Implementation of a Publicly Funded ThyroSeq v3 Program: A Retrospective Two-Center Cohort Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Identification of biological properties and molecular signatures to predict treatment response in patients with advanced HPV positive oropharyngeal cancer" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Nader Sadeghi

Research

Latest papers

Latest funding

Clinicopathological, Molecular, and Economic Outcomes of Bethesda III and IV Thyroid Nodules Following Implementation of a Publicly Funded ThyroSeq v3 Program: A Retrospective Two-Center Cohort Study.

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life.

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Prognostic Impact of Lymphovascular Invasion on Distant Metastasis in HPV-Negative Head and Neck Cancer.

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full Trial.

Single-stage functional lateral hemilaryngocricoidectomy for a locally advanced chondrosarcoma invading the hemicricoid.

Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Identification of biological properties and molecular signatures to predict treatment response in patients with advanced HPV positive oropharyngeal cancer

Role of CD109 in regulating cellular signaling and responses in skin and oral squamous cell carcinoma cells

Implementing an e-Intervention to Reduce Anxiety Symptoms and Improve Psychosocial Oncology Uptake In Patients Newly Diagnosed With Head and Neck Cancer: Pilot Randomized Controlled Trial

Frequent collaborators

Melissa Henry

Zeev Rosberger

Marie-Jeanne Kergoat

Marie-Jeanne Kergoat

Antoine Eskander

Christopher Lo

SAMPATH Loganathan

Robert Platt

Nancy Mayo

Michael Gupta

Sarah Khalife

Michael Meaney

Anie Philip

Maryam Tabrizian

Rui Fu

John de Almeida

Marc Gaudet

Ian Witterick

Houda Bahig

Matthew Cecchini

Philippe Lefrançois

Anthony Nichols

Daren Heyland

Eitan Prisman

Jianyu Li

Gerald Batist

Gerald Batist

Caroline Reinhold

Joseph Dort